Hosted on MSN
J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results
Johnson and Johnson (J&J) has announced the cancellation of its Phase III E.mbrace study examining Sanofi’s investigational vaccine for extraintestinal pathogenic Escherichia coli (E. Coli) after ...
(Reuters) - Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results